UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

þ		Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

o		Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission file number: 001-33304

Converted Organics Inc.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation or organization)		20-4075963 (I.R.S. Employer Identification No.)

137A Lewis Wharf, Boston, MA 02110
(Address of principal executive offices) (Zip Code)

(617) 624-0111
(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES þ NO o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES þ NO o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o		Accelerated filer o		Non-accelerated filer o		Smaller reporting company þ
				(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES o NO þ

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: As of November 11, 2011, there were 23,176,211 shares of our common stock outstanding.

 

 

     INDEX

		Page.
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements			3
Consolidated Balance Sheets as of September 30, 2011 (unaudited) and December 31, 2010 (as restated)			3
Consolidated Statements of Operations for the three and nine month periods ended September 30, 2011 and 2010 (unaudited)			4
Consolidated Statement of Changes in Stockholders’ Equity for the nine month period ended September 30, 2011 (unaudited)			5
Consolidated Statements of Cash Flows for the nine month periods ended September 30, 2011 and 2010 (unaudited)			6
Notes to Consolidated Interim Financial Statements (unaudited)			7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			34
Item 3. Quantitative and Qualitative Disclosures about Market Risk			60
Item 4. Controls and Procedures			61
PART II. OTHER INFORMATION
Item 1. Legal Proceedings			62
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			63
Item 3. Defaults Upon Senior Securities			63
Item 4. [Removed and Reserved]			63
Item 5. Other Information			63
Item 6. Exhibits			64
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-101 INSTANCE DOCUMENT
EX-101 SCHEMA DOCUMENT
EX-101 CALCULATION LINKBASE DOCUMENT
EX-101 LABELS LINKBASE DOCUMENT
EX-101 PRESENTATION LINKBASE DOCUMENT
EX-101 DEFINITION LINKBASE DOCUMENT

Item 1. Financial Statements

CONVERTED ORGANICS INC.
CONSOLIDATED BALANCE SHEETS

		September 30, 2011				December 31, 2010
		(Unaudited)				(As Restated)
ASSETS
CURRENT ASSETS
Cash		$	989,629			$	3,039,941
Accounts receivable, net			555,150				522,946
Inventories			226,715				126,406
Prepaid expenses and other assets			317,523				251,589
Deferred financing costs, net			140,798				276,667
Current assets of discontinued operations			—				14,500
Total current assets			2,229,815				4,232,049
Deposits and other non-current assets			587,831				575,596
Property and equipment, net			2,904,787				1,477,589
Goodwill			223,787				2,359,378
Intangible assets, net			11,242,993				11,879,265
Total assets		$	17,189,213			$	20,523,877
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Term note payable		$	—			$	350,000
Notes payable — related party			72,351				72,351
Accounts payable			2,067,579				2,393,388
Accrued expenses			652,929				656,412
Convertible notes payable, net of unamortized discount			2,384,959				306,404
Obligation to issue shares			205,357				1,560,715
Derivative liabilities — current			4,949,019				5,199,572
Deferred revenue			50,000				—
Liabilities of discontinued operations			564,418				2,438,253
Total current liabilities			10,946,612				12,977,095
Derivative liabilities			955,708				3,476,047
Total liabilities			11,902,320				16,453,142
COMMITMENTS AND CONTINGENCIES			—				—
STOCKHOLDERS’ EQUITY
Preferred stock, $1,000 stated value, authorized 10,000,000 shares			13,281,000				17,500,000
Common stock, $.0001 par value, authorized 500,000,000 shares at September 30, 2011 and 250,000,000 shares at December 31, 2010			14,230				8,547
Additional paid-in capital			99,156,204				84,882,411
Accumulated deficit			(107,554,226	)			(98,973,192	)
Accumulated other comprehensive income (loss)			56,341				(1,109	)
			4,953,549				3,416,657
Noncontrolling interests			333,344				654,078
Total stockholders’ equity			5,286,893				4,070,735
Total liabilities and stockholders’ equity		$	17,189,213			$	20,523,877

The accompanying notes are an integral part of these consolidated financial statements.

CONVERTED ORGANICS INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)

		Three month periods ended								Nine month periods ended
		September 30, 2011				September 30, 2010				September 30, 2011				September 30, 2010
Revenues		$	687,659			$	808,582			$	2,806,545			$	2,765,641
Cost of goods sold			515,284				583,703				1,973,710				2,020,752
Gross profit			172,375				224,879				832,835				744,889
Operating expenses
Selling, general and administrative expenses			1,361,634				4,011,974				7,480,445				10,413,049
Research and development			—				35,000				16,023				176,650
Amortization of intangible assets			221,457				72,001				664,099				216,006
Goodwill impairment			—				—				2,135,021				—
			1,583,091				4,118,975				10,295,588				10,805,705
Loss from continuing operations			(1,410,716	)			(3,894,096	)			(9,462,753	)			(10,060,816	)
Other income/(expenses)
Other income (expense)			(21,396	)			7,339				7,557				7,871
Gain on obligations to issue shares revaluation			82,143				—				1,355,358				—
Gain on settlement of debt			—				—				225,000				—
Derivative gain (loss)			(2,297,229	)			661,982				6,952,284				1,160,711
Loss on debt modification			(936,776	)			—				(936,776	)
Interest expense			(1,411,805	)			(4,627	)			(7,252,051	)			(15,883	)
			(4,585,063	)			664,694				(351,372	)			1,152,699
Loss from continuing operations before provision for income taxes			(5,995,779	)			(3,229,402	)			(9,111,381	)			(8,908,117	)
Provision for income taxes			—				—				—				—
Net loss from continuing operations			(5,995,779	)			(3,229,402	)			(9,111,381	)			(8,908,117	)
Income (loss) from discontinued operations			49,447				(18,685,007	)			195,918				(22,711,406	)
Net loss			(5,946,332	)			(21,914,409	)			(8,915,463	)			(31,619,523	)
Net loss attributable to noncontrolling interests			(187,904	)			—				(334,429	)			—
Net loss attributable to Converted Organics Inc. before other comprehensive loss			(5,758,428	)			(21,914,409	)			(8,581,034	)			(31,619,523	)
Other comprehensive income:
Foreign currency translation adjustment			85,449				—				71,145				—
Comprehensive loss			(5,672,979	)			(21,914,409	)			(8,509,889	)			(31,619,523	)
Comprehensive income attributable to noncontrolling interests			16,449				—				13,695				—
Comprehensive loss attributable to Converted Organics Inc.		$	(5,689,428	)		$	(21,914,409	)		$	(8,523,584	)		$	(31,619,523	)
Earnings (loss) per share, basic and diluted
Continuing operations		$	(0.43	)		$	(0.75	)		$	(0.80	)		$	(2.21	)
Discontinued operations		$	—			$	(4.33	)		$	0.02			$	(5.63	)
		$	(0.43	)		$	(5.08	)		$	(0.78	)		$	(7.84	)
Weighted average common shares outstanding			14,059,866				4,318,744				11,500,199				4,035,456

The accompanying notes are an integral part of these consolidated financial statements.

     

CONVERTED ORGANICS INC.
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 2011
(UNAUDITED)

																										Accumulated
		Preferred Stock Series A								Common Stock																Other												Total
		Shares Issued and								Shares Issued and								Additional				Accumulated				Comprehensive								Non-Controlling				Stockholders’
		Outstanding				Amount				Outstanding				Amount				Paid-in Capital				Deficit				Loss				Total				Interests				Equity
Balance, December 31, 2010 (As restated)			17,500			$	17,500,000				8,546,813			$	8,547			$	84,882,411			$	(98,973,192	)		$	(1,109	)		$	3,416,657			$	654,078			$	4,070,735
Common stock issued to settle convertible notes obligations			—				—				4,029,373				4,029				6,408,928				—				—				6,412,957				—				6,412,957
Common stock issued as compensation			—				—				506,570				506				1,557,319				—				—				1,557,825				—				1,557,825
Issuance of employee stock options			—				—				—				—				669,444				—				—				669,444				—				669,444
Issuance of common stock as payment of accounts payable			—				—				50,833				51				76,199				—				—				76,250				—				76,250
Issuance of common stock as payment to settle obligations of discontinued operations			—				—				320,000				320				1,343,680				—				—				1,344,000				—				1,344,000
Issuance of common stock in connection with conversion of preferred stock			(4,219	)			(4,219,000	)			776,980				777				4,218,223				—				—				—				—				—
Foreign currency translation adjustment			—				—				—				—				—				—				57,450				57,450				13,695				71,145
Net loss			—				—				—				—				—				(8,581,034	)			—				(8,581,034	)			(334,429	)			(8,915,463	)
Balance, September 30, 2011			13,281			$	13,281,000				14,230,568			$	14,230			$	99,156,204			$	(107,554,226	)		$	56,341			$	4,953,549			$	333,344			$	5,286,893

The accompanying notes are an integral part of these consolidated financial statements.

CONVERTED ORGANICS INC.

		Nine month periods ended
		September 30, 2011				September 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss		$	(8,915,463	)		$	(31,619,523	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization expense of intangibles and other assets			1,057,849				251,757
Depreciation and amortization of property and equipment			210,571				1,394,249
(Recovery of) provision for losses on accounts receivable			(75,875	)			—
Amortization of discounts on notes payable			6,967,644				—
Interest expense in connection with issuance of convertible debt			268,486				—
Common stock issued as compensation			1,557,825				349,639
Common stock issued as payment of accounts payable			76,250				—
Stock option compensation expense			669,444				1,305,812
Obligations to issue shares revaluation			(1,355,358	)			—
Gain on settlement of debt			(225,000	)			—
Gain on settlements of accounts payable			(302,057	)			—
Loss on write-down of construction costs			113,543				—
Loss on debt modification			936,776				—
Loss on impairment of long-term assets			2,135,021				15,430,685
Derivative gain			(6,952,284	)			(1,160,711	)
Changes in operating assets and liabilities:
(Increase) decrease in:
Accounts receivable			58,171				(567,244	)
Inventories			(100,309	)			337,833
Prepaid expenses and other current assets			(73,335	)			(129,024	)
Deposits and other non-current assets			(15,140	)			(48,240	)
Increase (decrease) in:
Accounts payable			(1,023,474	)			1,469,926
Accrued expenses			(231,269	)			2,854,432
Deferred revenue			50,000				—
Net cash used in operating activities			(5,167,984	)			(10,130,409	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment			(1,060,988	)			(446,930	)
Patent costs			(27,828	)			—
Purchase of other assets			—				(500,000	)
Net cash used in investing activities			(1,088,816	)			(946,930	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of debt obligations			(125,000	)			(1,540,009	)
Repayment of capital lease obligations			—				(8,751	)
Net proceeds from exercise of options			—				34,000
Net proceeds from stock offering			—				2,366,360
Deferred financing costs for short-term notes			(255,000	)			—
Net proceeds from short-term notes			4,500,000				—
Net cash provided by financing activities			4,120,000				851,600
Net effect of exchange rate changes on cash			86,488				—
NET DECREASE IN CASH			(2,050,312	)			(10,225,739	)
Cash, beginning of period			3,039,941				10,708,807
Cash, end of period		$	989,629			$	483,068
Supplemental cash flow information:
Cash paid during the period for:
Interest		$	23,267			$	808,679
Non-cash financing activities:
Equipment acquired through assumption of accounts payable		$	696,329			$	—
Common stock issued to settle convertible notes obligations			6,395,624				413,959
Fair value of derivatives issued in conjuction with debt and equity financing			4,667,269				968,096
Common stock and warrants issued as payment for accounts payable			—				1,501,600
Common stock issued as settlement of obligations of discontinued operations			1,344,000				—
Common stock issued in connection with conversion of preferred stock			4,219,000				—

The accompanying notes are an integral part of these consolidated financial statements.

CONVERTED ORGANICS INC.

NOTE 1 — BASIS OF PRESENTATION AND NATURE OF OPERATIONS

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these interim consolidated financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In management’s opinion, the unaudited interim consolidated financial statements and accompanying notes reflect all adjustments, consisting of normal and recurring adjustments, that are necessary for a fair presentation of its financial position and operating results for the periods presented.

The results of operations for the interim periods are not necessarily indicative of the results to be expected for the entire year. This Form 10-Q should be read in conjunction with the audited consolidated financial statements and notes thereto included in Converted Organics Inc.’s Form 10-K as of and for the year ended December 31, 2010.

NATURE OF OPERATIONS

Converted Organics Inc. and its subsidiaries (collectively the “Company”) utilize innovative clean technologies to establish and operate environmentally friendly businesses. The Company is dedicated to creating a cleaner, greener future, and operates using sustainable business practices that support this vision. The Company operates in three business areas: Organic Fertilizer, Industrial Wastewater Treatment and Vertical Farming.

Organic Fertilizer: The Company operates a processing facility that converts food waste and other raw materials into all-natural fertilizers, biostimulants, and soil amendment products.

Industrial Wastewater Treatment: Utilizing an innovative wastewater treatment process, Converted Organics’ Industrial Wastewater Resources business (“IWR”) provides a means of treating aqueous waste streams. This technology, which can use waste heat and renewable energy as fuel, produces only two byproducts: clean water vapor and landfill-appropriate solid residuals.

Vertical Farming: The Company engages in vertical farming through our TerraSphere business, which builds efficient systems for growing pesticide-free organic produce in a controlled indoor environment using its patented technology.

A summary of the Company’s subsidiaries is as follows:

Converted Organics of California, LLC (the “Gonzales facility”) is a California limited liability company and wholly-owned subsidiary. The Gonzales facility operates a plant in Gonzales, California, in the Salinas Valley and produces approximately 25 tons of organic fertilizer per day, which is sold primarily to the California agricultural market. The Gonzales

CONVERTED ORGANICS INC.

facility employs a proprietary method called High Temperature Liquid Composting (“HTLC”). The facility has been upgraded to enable it to accept larger amounts of food waste from waste haulers and may be upgraded, depending on demand, to have the capability to produce a dry product in addition to the current liquid fertilizer it produces.

Converted Organics of Woodbridge, LLC (the “Woodbridge facility”) is a New Jersey limited liability company and wholly-owned subsidiary, which was formed for the purpose of owning, constructing and operating the Company’s facility in Woodbridge, New Jersey. During 2010, the Company discontinued operations at the Woodbridge plant. The Company has reported the results of operations of Converted Organics of Woodbridge, LLC as discontinued operations within the consolidated financial statements (See Note 5).

Converted Organics of Rhode Island, LLC (“RILLC”) is an inactive subsidiary of Converted Organics Inc. RILLC has no assets or liabilities. RILLC was originally established for the purpose of operating a food waste to fertilizer plant in Rhode Island. The only asset that RILLC had acquired was an operating lease from the Rhode Island Resource Recovery Corporation (“RIRRC”) for a parcel of land which was intended to serve as the site for the planned plant. The Company did not have the resources to begin construction on a plant and therefore entered into a letter of intent to sell the operating lease rights to a third party who would also obtain a license from Converted Organics Inc. to operate the proposed facility. The letter of intent does not remain in effect, as the operating lease reverted back to the RIRRC in the fourth quarter of 2010. The RIRRC is a separate and distinct corporation, operated by the state of Rhode Island for the purpose of operating recycling facilities and the Company has no related party or affiliated relationship with that entity.

Converted Organics of Mississippi, LLC is a Mississippi limited liability company and wholly-owned subsidiary, which was formed for the purpose of hiring a sales force and adding a poultry litter-based fertilizer product to the Company’s existing product lines. The Company does not expect to have operating activity in this subsidiary during 2011.

TerraSphere Inc. (“TerraSphere”), a Delaware corporation and a wholly-owned subsidiary, was formed for the purpose of acquiring the membership interests of TerraSphere Systems LLC (“TerraSphere Systems”). On November 12, 2010, TerraSphere acquired a 95% membership interest in TerraSphere Systems (See Note 4). TerraSphere Systems has two subsidiaries; wholly owned PharmaSphere, LLC (“PharmaSphere”) and majority owned TerraSphere Systems Canada, Inc. (“TerraSphere Canada”). PharmaSphere’s business plan is to utilize TerraSphere Systems’ patented technology for the production of high value biocompounds sourced from plants and used as active pharmaceutical ingredients and for the production of transgenic plants (genetically engineered plants) for the biotechnology market. PharmaSphere has a wholly-owned subsidiary PharmaSphere Worcester, LLC, which was formed to build a facility in Worcester, Massachusetts utilizing PharmaSphere’s business plan. The building of the facility has not commenced. PharmaSphere has no revenue to date. TerraSphere Canada, located in Vancouver, British Columbia, operates the research and manufacturing facility for TerraSphere and is eighty-five percent owned by TerraSphere Systems.

GoLocalProduceRI, LLC On December 30, 2010, Converted Organics, Inc. purchased a majority ownership interest of the vertical farming entity GoLocalProduceRI, LLC located in Rhode Island, marking its entrance

CONVERTED ORGANICS INC.

into the vertical farming industry as owners and operators of what is expected to be the first TerraSphere facility in the United States (See Note 4).

PRINCIPLES OF CONSOLIDATION

The accompanying consolidated financial statements include the balances of Converted Organics Inc. and its wholly-owned subsidiaries, Converted Organics of California, LLC, Converted Organics of Woodbridge, LLC, Converted Organics of Mississippi, LLC, TerraSphere Inc. and its majority-owned subsidiaries Converted Organics of Rhode Island, LLC and GoLocalProduceRI, LLC. The minority-owned interests in its consolidated subsidiaries are included in the Company’s consolidated financial statements as noncontrolling interests. All intercompany transactions and balances have been eliminated in consolidation.

REVENUE RECOGNITION

Revenue is recognized when (i) persuasive evidence of a sales arrangement exists, (ii) delivery of the product or service has occurred, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.

The Company’s organic fertilizer operation generates revenues from two sources: product sales and tip fees. Product sales revenue comes from the sale of fertilizer products. Tip fee revenue is derived from waste haulers who pay the Company “tip” fees for accepting food waste generated by food distributors such as grocery stores, produce docks and fish markets, food processors and hospitality venues such as hotels, restaurants, convention centers and airports.

The IWWR operation will generate revenue by setting up treatment systems on customers’ sites and processing their wastewater on a price-per-gallon basis.

The Company’s vertical farming operation derives its revenues from licensing fees, and in the future expects to also derive revenues from license royalties, the sale of equipment and sales from the operation of the Company’s own growing facilities using the Company’s patented technology.

The Company grants exclusive licenses to use the vertical farming Growth System for the remaining term of the associated patents. The licenses provide for (i) the payment of an initial license fee in installments over periods ranging from nine months to one year, and (ii) the payment of continuing royalties based on a percentage of the licensee’s sales, subject to an annual minimum. The licenses are generally not transferable without the permission of the Company.

In order to grow plants using the technology granted by the license, the licensee will also be required to purchase equipment which incorporates the Growth system, either from the Company or from a manufacturer licensed or contracted by the Company.

The licenses are therefore part of a multi-element arrangement, for which revenue cannot be recognized until the delivered elements have stand alone value. The Company has determined that the elements delivered under these arrangements will have stand alone value at such time as the licensee has received both the license and the equipment, or the license and the Company’s permission to resell the license.

License fees received in cash or recorded as a receivable prior to the time the delivered elements have stand alone value are deferred as deferred revenue.

In addition, receivable installments due under the licenses which are not deemed to be reasonably assured of collection when the license was initially granted are recorded as an asset offset by a valuation allowance. When payments of such installments are received the related revenue is deferred if the elements delivered under that license do not yet have stand alone value.

RECLASSIFICATIONS

As a result of the Woodbridge facility operations being discontinued during the third quarter of 2010, certain items of the comparative interim period have been reclassified as discontinued operations. These reclassifications have no affect on previously reported net loss. See Note 14 for discussion of restated financial information.

IMPAIRMENTS

At June 30, 2011 the Company determined that the operating results for its vertical farming business, which is comprised principally of TerraSphere, together with revised projections of the near term operating results, required that the long-lived assets (principally patents subject to amortization) and goodwill of that business be tested for impairment. The projected undiscounted cash flows for the vertical farming business over the remaining life of the patents exceeded the carrying amount of the long-lived assets, and therefore no impairment of long lived assets was recorded. However, the June 30, 2011 fair value of the vertical farming goodwill, calculated on the basis of discounted cash flows, is less than the carrying amount of the vertical farming business goodwill, and therefore the Company recorded a goodwill impairment charge of $2.1 million at June 30, 2011 reflecting the impairment of all of the goodwill resulting from the November, 2010 acquisition of TerraSphere.

USE OF ESTIMATES

Among the most significant estimates used in the preparation of the Company’s consolidated financial statements are the projections of future cash flows from the Company’s business segments used in assessing whether there has been any impairment to the Company’s long-lived assets, intangible assets or goodwill and the assumptions utilized in the Company’s calculation of the fair value of derivative liabilities. These estimates are inherently uncertain and may require significant adjustments based on future events. The effect of any such adjustments could be significant.

CONVERTED ORGANICS INC.

Note 2 — GOING CONCERN/ MANAGEMENT’S PLAN OF OPERATIONS

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As reflected in the consolidated financial statements, the Company has an accumulated deficit, has suffered significant net losses and negative cash flows from operations, and has negative working capital, which circumstances raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

As reflected in the consolidated financial statements, the Company incurred a net loss of approximately $8.9 million for the nine months ended September 30, 2011, and as of September 30, 2011 has an accumulated deficit of approximately $107.6 million and a working capital deficiency of approximately $8.7 million. During 2010, the Company discontinued the operations at its Woodbridge facility, acquired a license to treat Industrial Waste Water and acquired the TerraSphere business. In addition, the Company currently has manufacturing capabilities at its Gonzales facility as a means to generate revenues and cash. Although the Gonzales facility is currently cash flow positive, the anticipated costs associated with corporate overhead and for the operations of TerraSphere will cause the Company to have negative cash flow in 2011. In addition, the Company feels that it will require cash, either through financing or equity transactions, in order to build out the IWR and TerraSphere projects planned for 2011.

Presently, the Company’s liquidity is limited to cash on hand at September 30, 2011. In addition, in connection with recent financings, the Company has warrants outstanding that if exercised could provide the Company with additional cash. However, the Company’s stock price has closed at both above and below the exercise price of these warrants, and it is not likely that any warrants would be exercised unless the price of its common stock was greater than the exercise price of the warrants. There is no assurance that the holders of the warrants will exercise the warrants in the near term, and as such, we may not receive these funds.

If the Company does not receive additional funds, whether as a result of the exercise of outstanding warrants, or otherwise, the Company will not have sufficient cash to be able to continue its operations. The Company has projected that there is sufficient cash to operate until the end of 2011 assuming there is no expenditures of cash on future IWR, TerraSphere, or fertilizer capital projects. However, the Company’s business strategy involves growing the IWR and TerraSphere divisions, and expects that the Company will require additional cash prior to the end of 2011. At this time, the Company does not have any commitments for additional financing, and there is no assurance that capital in any form will be available on terms and conditions that are acceptable or at all. If the Company docs not raise funds before it exhausts its current cash position the Company will be unable to continue operations. The Company anticipates that it will exhaust its cash position as of December 31, 2011 and unless additional financing can be secured (for which there are no commitments) the Company will not be able to continue operations after December 31, 2011. Therefore, in the fourth quarter of 2011, in order to conserve cash, the Company began to implement plans to continue California operations while curtailing all but essential personnel at the Corporate level and cease all operations at the TerraSphere division and all operations at the IWW division other than the operations at the South Canyon Land fill. In addition, the Company is in negotiations, with an investor, whereby the Company would spin off the TerraSphere division. These negotiations have not been completed.

CONVERTED ORGANICS INC.

NOTE 3 — NEW ACCOUNTING STANDARDS

In May 2011, the FASB issued ASU No. 2011-04 “Fair Value Measurement (Topic 820) — Amendments to Achieve Common Fair Value Measurements and Disclosure Requirements in U.S. GAAP and IFRSs” (“ASU No. 2011-04”) which will supersede most of the accounting guidance currently found in Topic 820 of FASB’s ASC. The amendments will improve comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with GAAP and International Financial Reporting Standards (“IFRS”). The amendments also clarify the application of existing fair value measurement requirements. These amendments include (1) the application of the highest and best use and valuation premise concepts, (2) measuring the fair value of an instrument classified in a reporting entity’s shareholders’ equity and (3) disclosing quantitative information about the unobservable inputs used within the Level 3 hierarchy. The guidance is effective for the Company’s interim and annual periods beginning after December 15, 2011 and will be applied prospectively.

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220) — Presentation of Comprehensive Income” (“ASU No. 2011-05”) which eliminates the option to present the components of other comprehensive income as part of the statement of stockholders’ equity. The amendments require that all nonowner changes in stockholders’ equity must be presented in a single continuous statement of comprehensive income or in two separate but consecutive statements. Regardless of whether an entity chooses to present comprehensive income in a single continuous statement or in two separate but consecutive statements the entity is required to present on the face of the financial statements reclassification adjustments for items that are reclassified from other comprehensive income to net income in the statement(s) where the components of net income and the components of other comprehensive income are presented. The guidance is effective for the Company’s interim and annual periods beginning after December 15, 2011 and will be applied prospectively.

In September 2011, the FASB issued ASU No. 2011-08, “Testing Goodwill for Impairment” (“ASU No. 2011-08”). The provisions of ASU No. 2011-08 permits an entity an option to first perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity believes, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is required. Otherwise, no further impairment testing is required. ASU No. 2011-08 includes examples of events and circumstances that may indicate that a reporting unit’s fair value is less than its carrying amount. The provisions of ASU No. 2011-08 are effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted provided that the entity has not yet performed its annual impairment test for goodwill.

CONVERTED ORGANICS INC.

NOTE 4 — ACQUISITIONS

TERRASPHERE SYSTEMS, LLC

On November 12, 2010, the Company acquired 95% of the membership interests of TerraSphere Systems, LLC. The acquisition will enable the Company to license TerraSphere’s patented Growth System, which is a system of modules and processes for growing plants in a controlled environment. The system uses and controls precise combinations of light, water, nutrition, gravity, centrifugal forces, and gasses to produce growing conditions that can be controlled and manipulated to result in desired plant growth and maximum crop production.

GOLOCALPRODUCERI, LLC

On December 30, 2010, the Company acquired 83.34% of GoLocalProduceRI, LLC, marking its entrance into the vertical farming industry as owners and operators of what is expected to be the first TerraSphere facility in the United States.

The unaudited pro forma consolidated financial information including continuing and discontinued operations for the three and nine month periods ended September 30, 2010 as though the above acquisitions had been completed at the beginning of the interim period is as follows:

		For the Three				For the Nine
		Months Ended				Months Ended
		September 30,				September 30,
		2010				2010
Revenue		$	817,765			$	3,468,190
Net loss		$	(31,389,145	)		$	(33,286,590	)
Net loss per share, basic and diluted		$	(4.55	)		$	(5.03	)
Weighted-average shares			6,898,307				6,615,019

CONVERTED ORGANICS INC.

NOTE 5 — DISCONTINUED OPERATIONS

In 2010, the Company discontinued operations at its facility in Woodbridge, New Jersey. The following table summarizes the components of the income (loss) from discontinued operations:

		For the Three Months Ended								For the Nine Months Ended
		September 30,								September 30,
		2011				2010				2011				2010
Revenue from discontinued operations		$	—			$	105,714			$	—			$	834,089
Income (loss) from discontinued operations		$	49,447			$	(18,685,007	)		$	195,918			$	(22,711,406	)

The Company recognized income from discontinued operations for the three and nine month periods ended September 30, 2011 as a result of favorable settlements with certain of its creditors. The Company does not expect to have any continuing positive cash flows from operations associated with the Woodbridge facility.

The following table provides the assets and liabilities of the Woodbridge facility, classified as discontinued operations, in the consolidated balance sheets dated September 30, 2011 and December 31, 2010:

		Sept 30,				Dec 31,
		2011				2010
Accounts receivable, net		$	—			$	14,500
Assets of discontinued operations		$	—			$	14,500
Accounts payable		$	535,645			$	837,606
Accrued expenses			—				1,571,874
Other liabilities			28,773				28,773
Liabilities of discontinued operations		$	564,418			$	2,438,253

On January 25, 2011, the Company paid cash of $150,000 and issued 320,000 shares of Company common stock with a fair value of $1,344,000 in payment for consulting services accrued at December 31, 2010 related to the settlement of certain Woodbridge obligations. The Company is actively working with its creditors to settle the remaining liabilities outstanding at September 30, 2011.

CONVERTED ORGANICS INC.

NOTE 6 — FAIR VALUE MEASUREMENTS

The Company applies Accounting Standards Codification Topic 820 Fair Value Measurements and Disclosures (“ASC 820”), which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

ASC 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety which requires judgment, and considers factors specific to the asset or liability.

The Company’s balances that are reported at fair value in the accompanying consolidated balance sheets as of September 30, 2011 and December 31, 2010 were as follows:

		Level of				Balance
		Hierarchy				Sept 30, 2011				Dec 31, 2010
Obligations to issue shares		Level 2				$	205,357			$	1,560,715
Derivative warrants and anti-dilution provision liabilities		Level 3					5,904,727				8,675,619

CONVERTED ORGANICS INC.

The following table reflects the change in Level 3 fair value of the Company’s derivative liabilities for the three and nine months ended September 30, 2011:

		Three				Nine
		months				months
		ended				ended
Balance, beginning of period		$	(2,812,630	)		$	(8,675,619	)
Settlements			124,575				1,405,320
Issuances			—				(4,667,269	)
Loss on debt modification			(919,443	)			(919,443	)
Net gains (loss)			(2,297,229	)			6,952,284
Balance, end of period		$	(5,904,727	)		$	(5,904,727	)

The Company has other non-derivative financial instruments, such as cash, accounts receivable, accounts payable, accrued expenses, notes payable and convertible notes payable, for which carrying amounts approximate fair value.

CONVERTED ORGANICS INC.

NOTE 7 — INVENTORIES

The Company’s inventories consisted of the following at:

		September 30,				December 31,
		2011				2010
Finished goods		$	190,268			$	104,690
Raw materials			36,447				21,716
Total inventories		$	226,715			$	126,406

CONVERTED ORGANICS INC.

NOTE 8 — DEBT

TERM NOTES

In connection with the Company’s acquisition of TerraSphere Systems, the Company assumed a note payable from a third party in the amount of $350,000, with a fixed interest rate of 15% per annum. On March 9, 2011, the Company entered into an agreement whereby in consideration of receiving a lump sum cash payment of $125,000, the third party released and discharged the Company from all obligations under the note.

NOTE PAYABLES — RELATED PARTY

In connection with the Company’s acquisition of TerraSphere Systems, the Company assumed unsecured note payables to William Gildea, Secretary of the Company and Edward Gildea, President of the Company, each of which have an interest rate of 10% per annum. The principal amount due totaled $72,351 at September 30, 2011 and December 31, 2010.

CONVERTIBLE NOTES PAYABLE

On December 17, 2010, the Company entered into a Securities Purchase Agreement (“Purchase Agreement”) with certain institutional investors (the “Buyers”) whereby, the Company agreed to sell to the Buyers certain notes and warrants. Pursuant to the terms of the Purchase Agreement, the Company agreed to sell to the Buyers convertible notes in the aggregate original principal amount of $4,990,000 (the “Notes”), which are convertible into shares of common stock. These Notes are to be purchased by Buyers in two tranches, the first of which involved the sale of Notes in the aggregate original principal amount of $3,939,473 (the “Initial Notes”). The Initial Notes are non interest bearing and were issued with an original issue discount of approximately 4.8%. The Company recorded the initial fair values of the conversion feature and the warrants up to the proceeds of the note ($3,750,000) as a discount on the Note which was amortized ratably over the six-month term.

On March 7, 2011 the second tranche of the sale of Notes was completed in the aggregate original principal amount of $1,050,527 (the “Additional Notes”) and was completed upon the satisfaction of the conditions to closing set forth in the Purchase Agreement. The Additional Notes were issued with an original issue discount of approximately 4.8%, and the proceeds from the Additional Notes were $1,000,000, with proceeds net of costs totaling $920,000. The Additional Notes are not interest bearing, unless the Company is in default on the Notes, in which case the Additional Notes carry an interest rate of 18% per annum.

The Notes were initially convertible into shares of Common Stock at a conversion price of $10.00 per share, provided that if the Company makes certain dilutive issuances (with limited exceptions), the conversion price of the Notes will be lowered to the per share price for the dilutive issuances. The Company also had the right, at its option, to permit the holder of the Notes to convert at a lower price specified by the Company for a period specified by the Company. The Company was required to repay the Notes in six equal installments commencing

CONVERTED ORGANICS INC.

February 1, 2011 (with respect to the Initial Notes) and six equal installments commencing April 8, 2011 (with respect to the Additional Notes), either in cash or in shares of is common stock. If the Company chooses to utilize shares of its common stock for the payment, the Company must make an irrevocable decision to use shares 22 trading days prior to the installment payment date, and the value of its shares will be equal to the lower of (i) the conversion price then in effect or (ii) 85% of the average of the three lowest closing sale prices of its common stock during the 20 trading day period prior to payment of the installment amount. If the Company chooses to make an installment payment in shares of its common stock, it must make a pre-installment payment of shares to the Note holder 20 trading days prior to the applicable installment date based on the value of its shares during the 20 trading days preceding the delivery of the notice to elect to pay in its shares.

On the installment date, to the extent the Company owed the Note holder additional shares in excess of the pre-installment shares to satisfy the installment payment, it issued the Note holder additional shares, and to the extent the Company issued excess shares, such shares were applied to future payments.

If an event of default occurs under the Notes, the Company must redeem the Notes in cash at the greater of 135% of the unconverted principal amount or 135% of the greatest equity value of the shares of common stock underlying the Notes from the date of the default until the redemption is completed. The conversion price of the Notes is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. The convertibility of the Notes may be limited if, upon exercise, the holder or any of its affiliates would beneficially own more than 4.9% of our Common Stock. No default occurred under these notes and they were paid in full prior to the end of September 30, 2011.

In connection with the sale of convertible notes and the issuance of the associated warrants to purchase common stock on March 7, 2011, the Company established a debt discount equal to the full amount of the notes, which reflects the original issue discount, the relative fair value of the warrants to the debt and reflects that the debt is classified as a derivative liability as the ability to repay the note in cash is deemed not to be within the Company’s control and the number of shares required to settle the obligation is not determinable. The total debt discount recognized was $1,050,527 and the interest expense recognized in addition to that amount was $268,486. The discount was being amortized over the term of the convertible notes. In addition, certain financing costs associated with the notes have been recorded as deferred financing costs and are being amortized over the term of the notes. At September 30, 2011, these notes are fully paid off and the Company issued 4,029,373 shares of its common stock as loan repayments on these notes.

On April 1, 2011, the Company entered into a Securities Purchase Agreement (“Agreement”) with an institutional investor (the “Buyer”) whereby, the Company agreed to sell to the Buyer certain notes and warrants. Pursuant to the terms of the Agreement, the Company agreed to sell to the Buyer a convertible note in the aggregate original principal amount of $3,850,000 (the “Original Note”), which is convertible into shares of common stock. The Original Note is non interest bearing and was issued with an original issue discount of approximately 9%. The Company recorded the initial fair values of the conversion feature and the warrants up to the gross proceeds of the note ($3,500,000) as a discount on the Original Note which will be amortized ratably over the six-month term. Net proceeds of the note were $3,325,000 at September 30,

CONVERTED ORGANICS INC.

2011, the carrying value of the Original note was $2,384,959 and the associated unamortized discount was $1,328,260.

The Original Note is initially convertible into shares of Common Stock at a conversion price of $4.00 per share, provided that if the Company makes certain dilutive issuances (with limited exceptions), the conversion price of the Original Note will be lowered to the per share price for the dilutive issuances. The Company also has the right, at its option, to permit the holder of the Original Note to convert at a lower price specified by the Company for a period specified by the Company. The Company is required to repay the Original Note in five equal installments commencing August 1, 2011. If the Company chooses to utilize shares of its common stock for the payment, the Company must make an irrevocable decision to use shares 23 trading days prior to the installment payment date, and the value of its shares will be equal to the lower of (i) the conversion price then in effect or (ii) 85% of the average of the three lowest closing sale prices of its common stock during the 20 trading day period prior to payment of the installment amount. If the Company chooses to make an installment payment in shares of its common stock, it must make a pre-installment payment of shares to the Original Note holder 20 trading days prior to the applicable installment date based on the value of its shares during the 20 trading days preceding the delivery of the notice to elect to pay in its shares. On June 24, 2011, the Company filed a registration statement in order to issue shares of its common stock to make the required loan repayments. The registration statement has not yet been declared effective. On August 9, 2011, the Company amended the payment due dates on its April 1, 2011 convertible note. The lender has agreed to extend the first payment (originally due August 1, 2011) to the earlier of the date that the underlying registration statement becomes effective or until six months after the issuance of the note when the restrictions on the shares lapse. In consideration of this amendment the Company has agreed to reprice certain of the warrants held by the lender to an exercise price of $0.50.

On the installment date, to the extent the Company owes the Note holder additional shares in excess of the pre-installment shares to satisfy the installment payment, it will issue the Note holder additional shares, and to the extent the Company has issued excess shares, such shares will be applied to future payments. Through September 30, 2011, the Company has not issued any shares of its common stock in satisfaction of loan repayments on the Original Note.

If an event of default occurs under the Original Note, the Company must redeem the Note in cash at the greater of 135% of the unconverted principal amount or 135% of the greatest equity value of the shares of common stock underlying the Note from the date of the default until the redemption is completed. The conversion price of the Original Note is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. The convertibility of the Note may be limited if, upon exercise, the holder or any of its affiliates would beneficially own more than 4.9% of our Common Stock.

In connection with the sale of convertible notes and the issuance of the associated warrants to purchase common stock on April 1, 2011, the Company established a debt discount equal to the full amount of the note, which reflects the original issue discount, the relative fair value of the warrants to the debt and reflects that the debt is classified as a derivative liability as the ability to repay the note in cash is deemed not to be within the Company’s control and the number of shares required to settle the obligation is not determinable. The total debt discount recognized was $3,398,783. The discount is being amortized over the term of the convertible notes. In addition, certain financing costs associated with the note has been recorded as deferred financing costs and are being amortized over the term of the notes.

The Company applies Accounting Standards Codification Topic 470 Modifications and Extinguishments (“ASC 470”), which defines a debt modification and provides guidance on whether an exchange of debt instruments with the same creditor constitutes an extinguishment and whether a modification of a debt instrument should be accounted for in the same manner as an extinguishment. ASC 470 establishes that a modification exists if the terms of the embedded conversion option from which the change in the fair value of the embedded conversion option (calculated as the difference between the fair value of the embedded conversion option immediately before and after the modification or exchange) is at least 10 percent of the carrying amount of the original debt instrument immediately before the modification or exchange. On July 31, 2011, the effective date of the April 2011 convertible note amendment, the Company measured the fair value of the embedded conversion option and determined that the change in fair value immediately before and after the modification was greater than 10 percent resulting in a debt modification. In accordance with ASC 470 the Company recognized a loss of $936,776 on the accompanying consolidated statement of operations and comprehensive loss.

CONVERTED ORGANICS INC.

NOTE 9 — DERIVATIVE INSTRUMENTS

On December 17, 2010, pursuant to the terms of the Purchase Agreement, the Company issued to the Buyers warrants to acquire shares of common stock, in the form of three warrants: (i) “Series A Warrants”, (ii) “Series B Warrants”, and (iii) “Series C Warrants” (collectively, the “December Warrants”). The Warrants were issued in two tranches on the dates the Initial Notes and Additional Notes were issued, on a pro rata basis based on the principal amount being issued in the applicable closing based on the aggregate principal amount that could be issued at both closings.

The Series B Warrants became exercisable on February 28, 2011, the date upon which shareholder approval was obtained in connection with the financing, and expire on November 28, 2011. The Series B Warrants provide that the holders are initially entitled to purchase an aggregate of 499,000 shares (warrants to purchase 393,947 shares of Common Stock were issued at the Initial Closing and a warrant to purchase 105,053 shares of Common Stock were issued at the Additional Closing which occurred on March 7, 2011) at an initial exercise price of $10.00 per share. If the Company makes certain dilutive issuances (with limited exceptions), the exercise price of the Series B Warrants will be lowered to the per share price for the dilutive issuances. In addition, the exercise price of the Series B Warrants will adjust to the average of the Installment Conversion Prices used to repay the Initial Notes. The floor price for the exercise price of the Series B Warrants is $3.45. The number of shares underlying the Series B Warrants will adjust whenever the exercise price adjusts, such that at all times the aggregate exercise price of the Series B Warrants will be $4,990,000 ($3,939,473 for the Series B Warrants issued in the Initial Closing and $1,050,527 for the Series B Warrants issued at the Additional Closing). During August 2011, in connection with amending its April 2011 convertible note, these Series B Warrants were repriced to $0.50 therefore, as of September 30, 2011, the exercise price of the Series B Warrants is $0.50 per share and there are 1,467,647 shares underlying the Series B Warrants.

The Series A and Series C Warrants became exercisable on February 28, 2011, the date upon which shareholder approval was obtained in connection with the financing, and have a five year term. The Series A Warrants provide that the holders are initially entitled to purchase an aggregate of 249,500 shares (warrants to purchase 196,974 shares of common stock were issued at the Initial Closing and warrants to purchase 52,526 shares of common stock were issued at the Additional Closing which occurred on March 7, 2011) at an initial exercise price of $10.00 per share. The Series C Warrants provide that the holders are initially entitled to purchase an aggregate of 249,500 shares (warrants to purchase 196,974 shares of common stock were issued at the Initial Closing and warrants to purchase 52,526 shares of common stock were issued at the Additional Closing) at an exercise price of $10.00 per share; provided that the Series C Warrants may only be exercised by each holder in the same proportion as such holder has already exercised its Series B Warrants.

If the Company makes certain dilutive issuances (with limited exceptions), the exercise price of the Series A and Series C Warrants will be lowered to the per share price for the dilutive issuances. In addition, the exercise price of the Series A and Series C Warrants will adjust to the average of the Installment Conversion Prices used to repay the Initial Notes. During August 2011, in connection with amending its April 2011 convertible note these Series A and C

CONVERTED ORGANICS INC.

Warrants were repriced to $0.50, therefore as of September 30, 2011, the exercise price of the Series A Warrants and Series C Warrants is $0.50 per share.

On April 17, 2011, pursuant to the terms of the Purchase Agreement, the Company issued to the Buyer warrants to acquire shares of common stock, in the form of three warrants: (i) “Series A Warrants”, (ii) “Series B Warrants”, and (iii) “Series C Warrants” (collectively, the “April Warrants”).

The Series B Warrants became exercisable on June 13, 2011, the date upon which shareholder approval was obtained in connection with the financing, and expire on March 13, 2012. The Series B Warrants provide that the holders are initially entitled to purchase an aggregate of 914,375 shares at an initial exercise price of $4.125 per share. If the Company makes certain dilutive issuances (with limited exceptions), the exercise price of the Series B Warrants will be lowered to the per share price for the dilutive issuances. In addition, the exercise price of the Series B Warrants will adjust to the average of the Installment Conversion Prices used to repay the Notes. The floor price for the exercise price of the Series B Warrants is $3.40. The number of shares underlying the Series B Warrants will adjust whenever the exercise price adjusts, such that at all times the aggregate exercise price of the Series B Warrants will be $3,771,797. During August 2011, in connection with amending its April 2011 convertible note these Series B Warrants were repriced to $0.50, therefore as September 30, 2011, the exercise price of the Series B Warrants is $0.50 per share and there are 1,109,352 shares underlying the Series B Warrants.

To the extent the Company enters into a fundamental transaction (as defined in the Series B Warrants and which include, without limitation, the Company entering into a merger or consolidation with another entity, selling all or substantially all of its assets, or a person acquiring 50% of the Company’s common stock), the Company has agreed to purchase the Series B Warrants from the holders at their Black-Scholes value.

If the Company’s common stock trades at a price at least 200% above the Series B Warrants exercise price for a period of 10 trading days at any time after the Company obtains shareholder approval (as discussed above), the Company may force the exercise of the Series B Warrants if the Company meets certain conditions.

The Series A and Series C Warrants are exercisable six months and one day after issuance and have a five year term commencing on June 13, 2011. The Series A Warrants provide that the holders are initially entitled to purchase an aggregate of 481,250 shares. The Series C Warrants provide that the holders are initially entitled to purchase an aggregate of 434,329 shares. If on the expiration date of the Series B Warrants, a holder of such warrant has not exercised such warrant for at least 50% of the shares underlying such warrant, the Company has the right to redeem from such holder its Series C Warrant for $10,000 under certain circumstances. On August 9, 2011, as part of the restructuring of the Note described above, the Company agreed to lower the exercise price of the Series A and Series C Warrants to $0.50 per share.

If the Company makes certain dilutive issuances (with limited exceptions), the exercise price of the Series A and Series C Warrants will be lowered to the per share price for the dilutive issuances. In addition, the exercise price of the Series A and Series C Warrants will adjust to the

CONVERTED ORGANICS INC.

average of the Installment Conversion Prices used to repay the Initial Notes. As of the September 30, 2011, the exercise price of the Series A Warrants and Series C Warrants is $0.50 per share.

To the extent the Company enters into a fundamental transaction (as defined in the Series A and Series C Warrants and which include, without limitation, the Company entering into a merger or consolidation with another entity, selling all or substantially all of its assets, or a person acquiring 50% of the Company’s common stock), the Company has agreed to purchase the Series A and Series C Warrants from the holder at their Black-Scholes value.

The exercise price of all the Warrants is subject to adjustment in the case of stock splits, stock dividends, combination of shares and similar recapitalization transactions. The exercisability of the Warrants may be limited if, upon exercise, the holder or any of its affiliates would beneficially own more than 4.9% of the Company’s common stock. The Note may not be converted if the total number of shares that would be issued would exceed 19.99% of the Company’s common stock on the date the Purchase Agreement was executed prior to the Company receiving shareholder approval (as discussed above).

As of September 30, 2011, the Company has recognized the following warrants as derivative instruments:

																														Fair
										Outstanding								Exercised				Outstanding				Exercisable				Value at
		Class/								at Dec 31,								or				at Sept 30,				at Sept 30,				Sept 30,
Issue Date		Series				Price				2010				Issued				Canceled				2011				2011				2011
05/07/09**		Class C				$	0.50				88,500				—				—				88,500				88,500			$	27,279
05/07/09**		Class D				$	0.50				41,500				—				—				41,500				41,500			$	12,747
09/08/09		Class G				$	0.50				250,000				—				—				250,000				250,000			$	94,041
04/22/10		Class I				$	0.50				116,336				—				—				116,336				—			$	45,148
12/17/10 *		Series A				$	0.50				196,974				52,526				—				249,500				249,500			$	97,830
12/17/10 *		Series B				$	0.50				393,947				1,073,700				—				1,467,647				1,467,647			$	265,086
12/17/10 *		Series C				$	0.50				196,974				52,526				—				249,500				249,500			$	97,830
04/01/11		Series A				$	0.50				—				481,250				—				481,250				481,250			$	191,975
04/01/11		Series B				$	0.50				—				1,109,352				—				1,109,352				1,109,352			$	245,661
04/01/11		Series C				$	0.50				—				434,329				—				434,329				434,329			$	173,258
																														1,250,855

CONVERTED ORGANICS INC.

     Class C and 6.500 Class D warrants which remained at $10.00 and $10.20 respectively.

In August 2011, the Company amended certain provisions of its April 2011 convertible note financing and as a result all of the warrants listed above, with the exception of certain Class C and Class D warrants, were repriced to $0.50. The Company recorded a charge in its statement of operations for the three months ended September 30, 2011 of $919,443 associated with the debt modification.

The Company also recognized certain conversion features issued in conjunction with debt as derivative instruments:

						Outstanding												Outstanding				Exerciseable				Fair Value
						at												at				at				at
						December 31,								Exercised				September 30,				September 30,				September 30,
Issue Date		Price				2010				Issued				or Canceled				2011				2011				2011
December 17, 2010		$	10.00				1,428,398				—				1,428,398				—				—			$	—
March 7, 2011		$	10.00				—				345,159				345,159				—				—			$	—
April 1, 2011		$	4.00				—				11,267,193				—				11,267,193				11,267,193			$	4,438,272

The amount of conversion features issued during 2011 on the April 2011 derivative instrument has increased as the conversion stock price has decreased from the original conversion price of $4.00.

The warrants and conversion features above were revalued at September 30, 2011 using a binomial lattice pricing model using certain assumptions related to the probability of exercise and the following:

Risk free interest rate			0.10% — 2.55	%
Dividend yield			-0-
Volatility			78%—205	%
Expected term		3 months to 5 years

In addition to the above derivative transactions, on November 12, 2010, the Company completed the acquisition of TerraSphere Systems LLC, where it determined that as a result of an anti-dilution provision included in the purchase agreement, certain additional shares may have to be issued. The Company estimated that approximately 440,000 shares could be issued and classified the anti-dilution provision as a derivative liability. As of September 30, 2011, the Company revalued the derivative liability to $215,600 based on the closing share price of the stock on that date.

The derivative liability reflected on the consolidated balance sheet at September 30, 2011 totaled $5,904,727 and the derivative gain(loss) for the three and nine month periods ended September 30, 2011 was ($2,297,229) and $6,952,284, respectively.

CONVERTED ORGANICS INC.

NOTE 10 — STOCKHOLDERS’ EQUITY

STOCK ISSUANCES

On January 25, 2011 the Company issued 320,000 shares of its common stock to a consultant satisfying a $1,344,000 accrual for services rendered in connection with the settlement of certain Woodbridge obligations.

On February 23, 2011, the Company issued 216,500 restricted shares at $3.70 (the closing price as of the date of issuance) to certain employees under the Amended and Restated 2006 Stock Option Plan. The statement of operations and comprehensive loss for the nine month period ended September 30, 2011 includes a charge of $801,050 for this compensation.

During April 2011, the Company issued 290,070 shares of its common stock as compensation under its stock option plan. These shares were issued to employees and directors and are restricted for a period of two years from issuance. The Company recorded compensation expense of $756,775 in its statement of operations and comprehensive loss for the nine month period ended September 30, 2011, based upon the closing price of the shares on the commitment date.

On June 20, 2011, the Company issued 776,980 shares of its common stock in exchange for the return of 4,219 shares of its preferred stock.

On June 10, 2011, the Company issued 50,833 shares of its common stock to vendors for services. The shares are restricted for a period of six months. The Company reduced the vendor payables by $76,250 based upon the closing price of the shares on the commitment date.

During the nine month period ended September 30, 2011 the Company issued 4,029,373 shares of its common stock as loan repayments which reduced the balance on the convertible notes by $6,412,957.

WARRANTS

In addition to the warrants classified as derivatives, the Company has also recognized certain warrants as equity instruments.

The following table sets forth the outstanding warrants classified as equity instruments as of September 30, 2011:

						Outstanding																Outstanding				Exercisable
						at																at				at
						December 31,																September 30,				September 30,
Warrants		Price				2010				Issued				Exercised				Canceled				2011				2011
Class B		$	110.00				264,803				—				—				—				264,803				264,803
Class E		$	16.30				150,000				—				—				—				150,000				150,000
Class F		$	0.50				58,500				—				—				—				58,500				58,500
Class H		$	13.00				1,725,000				—				—				—				1,725,000				1,725,000
Class J		$	5.40				162,333				—				—				—				162,333				162,333
Class K		$	5.40				115,741				—				—				—				115,741				115,741

CONVERTED ORGANICS INC.

In the event all outstanding warrants are exercised, including those classified as derivatives and those classified as equity, the Company has adequate shares authorized to meet these obligations.

In August 2011, the Company amended certain provisions of its April 2011 convertible note financing and as a result the Class F Warrants listed above were repriced from $10.25 to $0.50. The Company recorded a charge in its statement of operations for the three months ended September 30, 2011 of $17,333 associated with the modification.

STOCK OPTIONS

During the nine month period ended September 30, 2011, the Company issued 317,570 stock options to employees and directors under its stock option plan. The Company calculated a compensation expense associated with the issuance of these options of $699,444 using the Black-Scholes pricing model. The Company assumed a five year term, risk free interest rate of 1.9%, average volatility of 113.6% and exercise prices of $1.50 to $2.70.

Stock option activity for the nine month period ended September 30, 2011 is as follows:

						Weighted				Weighted
						Average				Average
						Exercise				Remaining
		Stock				Price per				Life
		Options				Share				(Years)
Outstanding and exercisable at December 31, 2010			364,380			$	16.40				8.8
Granted			282,802				2.70
Granted			21,868				2.20
Granted			12,900				1.50
Forfeited			(2,400	)			6.10
Outstanding and exercisable at September 30, 2011			679,550			$	10.00				8.2

CONVERTED ORGANICS INC.

NOTE 11 — SEGMENT REPORTING

The Company has three lines of business, which are (1) organic fertilizer, (2) vertical farming and (3) industrial wastewater treatment and based on the nature of products and services offered, the Company has determined each line of business is a reportable segment at September 30, 2011.

The Company evaluates performance based on several factors, of which the primary financial measure is business segment operating income. There were no intersegment sales for the three and nine months ended September 30, 2011. The discreet financial information is presented below as of and for the three and nine month periods ended September 30, 2011:

		For the Three Months Ended September 30, 2011
														Corporate
		Organic				Vertical				Industrial				and
		Fertilizer				Farming				Wastewater				Eliminations				Consolidated
Revenues		$	579,831			$	—			$	107,828			$	—			$	687,659
Operating loss (1)			(186,274	)			(465,529	)			(53,260	)			(705,653	)			(1,410,716	)
Depreciation and amortization(2)			106,662				161,821				33,335				55,568				357,386
Interest expense(3)			—				1,824				—				1,409,981				1,411,805
Net loss			(186,274	)			(512,277	)			(53,260	)			(5,194,521	)			(5,946,332	)

		For the Nine Months Ended September 30, 2011
														Corporate
		Organic				Vertical				Industrial				and
		Fertilizer				Farming				Wastewater				Eliminations				Consolidated
Revenues		$	2,497,923			$	—			$	308,622			$	—			$	2,806,545
Operating loss (1)			(256,828	)			(4,023,305	)			(104,324	)			(5,078,296	)			(9,462,753	)
Depreciation and amortization(2)			317,946				484,753				72,222				393,499				1,268,420
Interest expense(3)			—				13,898				—				7,238,153				7,252,051
Net loss			(256,828	)			(3,841,893	)			(104,324	)			(4,712,418	)			(8,915,463	)
Total assets (4)			3,556,195				10,667,097				2,049,482				916,439				17,189,213
Goodwill			—				223,787				—				—				223,787
Property and equipment additions			155,062				2,255				1,600,000				—				1,757,317

CONVERTED ORGANICS INC.

	(2)		Depreciation and amortization expense associated with property and equipment, intangibles and deferred financing fees. Corporate amortization expense relates to deferred financing fees.
	(3)		Corporate interest expense is primarily related to amortization of discounts on convertible notes payable.
	(4)		Total business assets are the owned or allocated assets used by each business. Corporate assets consist of cash, prepaid expenses, certain other assets and deferred financing costs.

As of September 30, 2010, the Company was a single reportable segment.

Revenues are attributable to geographic areas based on the locations of the customers, which are primarily within the continental United States. The fertilizer segment derived approximately $390,000 or 67% of its revenues from three customers (AO Farming Operations — 30%; NH3 Service Company — 20%; and Verdi Tech Services — 17%); the industrial wastewater segment derived 100% of its revenue from one customer, South Canyon Waste Systems, Inc. for the three month period ended September 30, 2011. For the nine month period ended September 30, 2011, the fertilizer segment derived approximately $1,327,000 or 54% of its revenues from four customers (Verdi Tech — 12%; American Farms — 13%; NH3 Servcies — 13%; and Crop Production Services — 16%); and the industrial wastewater segment derived 100% of its revenue from one customer, South Canyon Waste Systems, Inc. In both the three and nine month period ended September 30, 2011, the TerraSphere segment had no reportable income.

CONVERTED ORGANICS INC.

NOTE 12 — LEGAL PROCEEDINGS

The Company is not currently aware of any pending or threatened legal proceeding to which it is or would be a party, or any proceedings being contemplated by governmental authorities against it, or any of its executive officers or directors relating to the services performed on the Company’s behalf, except as follows.

On December 11, 2008, the Company received notice that a complaint had been filed in a putative class action lawsuit on behalf of 59 persons or entities that purchased units pursuant to a financing terms agreement, or FTA, dated April 11, 2006, captioned Gerald S. Leeseberg, et al. v. Converted Organics, Inc., filed in the U.S. District Court for the District of Delaware. The lawsuit alleges breach of contract, conversion, unjust enrichment, and breach of the implied covenant of good faith in connection with the alleged failure to register certain securities issued in the FTA, and the redemption of the Company’s Class A warrants in November 2008. The lawsuit seeks damages related to the failure to register certain securities, including alleged late fee payments, of approximately $5.25 million, and unspecified damages related to the redemption of the Class A warrants. In February 2009, the Company filed a Motion for Partial Dismissal of Complaint. On October 7, 2009, the Court concluded that Leeseberg has properly stated a claim for actual damages resulting from the Company’s alleged breach of contract, but that Leeseberg has failed to state claims for conversion, unjust enrichment and breach of the implied covenant of good faith, and the Court dismissed such claims. On November 6, 2009, the Company filed its answer to the Complaint with the Court. On March 4, 2010, the parties participated in a conference, and began discussing discovery issues. Plaintiff filed a Motion for Class Certification on June 22, 2010, which was denied on November 22, 2010. On March 3, 2011, the court denied the Company’s motion for partial summary judgment. On March 25, 2011, some individual investors filed a new complaint against the Company asserting similar claims to those in the Leeseberg litigation. The Court consolidated this case with the existing lawsuit and, on May 12, 2011, Plaintiffs filed an Amended Complaint. On June 6, 2011, the Company filed its answer to consolidated complaint and counter claims against Plaintiffs. The Parties have been engaged in settlement negotiations and have reached a settlement agreement. It is anticipated that the settlement will be funded by the insurance provider and, accordingly, no loss has been recorded related to these matters.

Related to the above matter, in December 2009, the Company filed a complaint in the Superior Court of Massachusetts for the County of Suffolk, captioned Converted Organics Inc. v. Holland & Knight LLP. The Company claims that in the event it is required to pay any monies to Mr. Leeseberg and his proposed class in the matter of Gerald S. Leeseberg, et al. v. Converted Organics, Inc., that Holland & Knight should make the Company whole, because its handling of the registration of the securities at issue in the Leeseberg lawsuit caused any loss that Mr. Leeseberg and other putative class members claim to have suffered. Holland & Knight has not yet responded to the complaint. Holland and Knight has threatened to bring counterclaims against Converted Organics for legal fees allegedly owed, which we would contest vigorously. On May 12, 2010, the Superior Court stayed the proceedings, pending resolution of the Leeseberg litigation. At this early stage in the case, the Company is unable to predict the likelihood of an unfavorable outcome, or estimate any loss/gain.

CONVERTED ORGANICS INC.

On May 19, 2009, the Company received notice that a complaint had been filed in the Middlesex County Superior Court of New Jersey, captioned Lefcourt Associates, Ltd. v. Converted Organics of Woodbridge, et al. The lawsuit alleged private and public nuisances, negligence, continuing trespasses and consumer common-law fraud in connection with the odors emanating from the Woodbridge facility and its alleged, intentional failure to disclose to adjacent property owners the possibility of the facility causing pollution and was later amended to allege adverse possession, acquiescence and easement. The lawsuit sought enjoinment of any and all operations which in any way cause or contribute to the alleged pollution, compensatory and punitive damages, counsel fees and costs of suit and any and all other relief the Court deems equitable and just. On April 12, 2010, the Middlesex County Superior Court of New Jersey issued an administrative order settlement dismissing without prejudice the matter of Lefcourt Associates, Ltd. v. Converted Organics of Woodbridge, et al. On June 8, 2010, Lefcourt Associates, Ltd re-filed their lawsuit but before a different court, the Chancery Division in Bergen County. The Company filed a motion to transfer the action back to the original court in Middlesex County, which was granted and sought to have the lawsuit dismissed, which was granted in part on August 27, 2010. The Court limited the plaintiff’s claims to the events in part that occurred after the dismissal of the prior action. Plaintiffs’ appealed the order dismissing their first lawsuit with prejudice, and the appellate court reversed the dismissal with prejudice but the first lawsuit still remains dismissed without prejudice. Due to the appellate decision, plaintiffs filed a motion to reconsider the decision made in the action, which was granted in part on July 28, 2011. The nuisance damages issue was reopened for 60 days. At the expiration of the 60 day period, we renewed the summary judgement motion, our motion for summary judgement was granted on November 4, 2011 and the only claim that remains before the court is the plantiffs right to make an application for legal fees. We plan to vigorously defend this matter and are unable to estimate any losses that may be incurred as a result of this litigation and upon its eventual disposition. Accordingly, no loss has been recorded related to this matter.

On August 25, 2011, TerraSphere, Inc, our wholly owned subsidiary, was named as a defendant in an action filed in the United States district court for the eastern district of Michigan against TerraSphere Systems, LLC and TerraSphere, Inc. The plantiff, alleges, among other things breach of fiduciary responsibilities regarding a joint venture agreement. The parties have agreed to an extension until November 30, 2011 to try and resolve the matter. In the event that the lawsuit can’t be resolved we plan to vigorously defend this matter. At this time we are unable to estimate any losses that may be incurred as a result of this litigation and upon its eventual disposition. Accordingly, no loss has been recorded relating to this matter.

NOTE 13 — SUBSEQUENT EVENTS

On October 19, 2011, the Company entered into an agreement, with its lender, pursuant to which the convertible note issued on April 1, 2011, as previously amended on August 9, 2011, in the aggregate original principal amount of $3,850,000 was amended. Pursuant to the original terms of the Note, the conversion price (“Conversion Price”) of the Note was $4.00, subject to adjustment as set forth in the Note. Pursuant to the Agreement, the parties agreed to change the definition of Conversion Price to mean, as of any conversion date or other date of determination, the lowest of (i) $4.00 (subject to adjustment as provided in the Note), (ii) the price which is equal to the product of (1) 85% multiplied by (2) the quotient of (A) the sum of each of the three (3) lowest closing sale prices of the common stock during the twenty consecutive trading day period immediately preceding the applicable conversion date or other date of determination (as the case may be) divided by (B) three (3) and (iii) the price which is equal to the product of (I) 85% multiplied by (II) the closing sale price of the common stock on the trading day immediately preceding the applicable conversion date or other date of determination (as the case may be).

On November 2, 2011, The Company entered into an agreement, with its lender, to exchange the convertible note issued on April 1, 2011, and amended on August 9, 2011 and October 19, 2011, in the aggregate original principal amount of $3,850,000, which had $3,474,797 of principal outstanding on November 2, 2011, for a senior secured convertible note in the aggregate original

CONVERTED ORGANICS INC.

principal amount of $3,474,797 (the “New Note”). The terms of the New Note are substantially identical to the terms of the Original Note (with amendments), provided that the Company is not required to amortize payment for the New Note and the principal and interest on the New Note is now due on May 2, 2012, instead of February 17, 2012. The lender may convert all or part of the new note prior to maturity.

On October 20, 2011 the Company began to issue shares of its common stock to convert, first the convertible note dated April 1, 2011 and then the “New Note” dated November 2, 2011. The Company has issued 8,945,643 for principal reduction on these notes.

On October 31, 2011, the Company announced that its Board of Directors agreed to separate converted Organics, Inc and TerraSphere Systems Inc and declared a special stock dividend of common stock of TerraSphere Systems Inc, to the converted Organics shareholders.

On November 7, 2011, the Company implimented a one for ten (1:10) reverse split of its common stock. The effect of the reverse stock split is retroactively reflected in the accompanying financial statements and footnotes.

On November 8, 2011, the Company announced the resignation of one of its outside directors.

CONVERTED ORGANICS INC.

NOTE 14 — RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS

The accompanying financial statements as of and for the nine months ended September 30, 2011 reflect the effects of the Company’s restatement of its financial statements for the year ended December 31, 2010 and for the six months ended June 30, 2011.

The Company restated its financial statements for the year ended December 31, 2010 to correct the amounts recorded in the Company’s preliminary allocation related to the November 12, 2010 acquisition of TerraSphere as the result, among other things, of TerraSphere’s restatement of its own financial statements for the nine months ended September 30, 2010 to correct its revenue recognition accounting. The Company has corrected its preliminary allocation related to the TerraSphere accounts receivable accordingly. The Company also corrected its assessment of the likelihood of the payment of the Milestone Two contingent payment (payable if TerraSphere receivables of $2 million are collected by February 28, 2011), and the resulting amount recorded as the fair value of this element of the acquisition cost. The net effect of these changes in the acquisition accounting affected the goodwill recorded when TerraSphere was acquired.

The following sets forth the changes to the determination of the acquisition costs and the preliminary allocation of the acquisition cost:

		As previously				Restatement				As
		reported				adjustment				restated
Components of acquisition cost
Election of option one		$	2,961,000							$	2,961,000
Election of option two			4,490,000								4,490,000
Milestone One			1,403,000								1,403,000
Milestone two			711,000				(673,579	)			37,421
Milestone three and four			1,684,000								1,684,000
Anti-dilution			837,000								837,000
		$	12,086,000							$	11,412,421
Allocation of acquistion cost
Cash		$	41,679							$	41,679
Accounts receivable			2,690,000				(1,615,000	)			1,075,000
Other assets			274,313								274,313
Leasehold improvements			176,181								176,181
Construction in progress			97,306								97,306
Patents			10,000,000								10,000,000
Goodwill			1,193,600				941,421				2,135,021
Assumption of liabilities			(1,738,435	)							(1,738,435	)
Non-controlling interest			(648,644	)							(648,644	)
		$	12,086,000							$	11,412,421

In addition, as the result of the reduction in the amount assigned to the accounts receivable upon the acquisition of TerraSphere, the bad debt expense the Company recorded for those

CONVERTED ORGANICS INC.

receivables during the period November 12, 2010 to December 31, 2010 was reduced from $2,283,000 to $725,000.

The Company also restated its preliminary allocation of the purchase price for GoLocalProduceRI, LLC to allocate $250,000 of the purchase price previously allocated to goodwill to the license rights which the Company sold to GoLocalProduceRI, LLC in November, 2010 and reacquired as the result of this acquisition.

The following sets forth the effect of the restatement on the affected financial statement line items:

		As previously				Restatement				As
		reported				adjustment				restated
For the year ended December 31, 2010
Selling, general and administrative expenses		$	14,625,568			$	(1,558,000	)		$	13,067,568
Loss from continuing operations			(14,277,559	)			1,558,000				(12,719,559	)
Loss from continuing operations before provision for income taxes			(16,039,025	)			1,558,000				(14,481,025	)
Loss from continuing operations			(16,039,025	)			1,558,000				(14,481,025	)
Net loss			(50,729,383	)			1,558,000				(49,171,383	)
Net loss attributable to noncontrolling interest			(168,156	)			77,900				(90,256	)
Net loss attributable to Converted Organics, Inc. before other comprehensive income			(50,561,227	)			1,480,100				(49,081,127	)
Comprehensive loss			(50,562,600	)			1,480,100				(49,004,500	)
Comprehensive loss attributable to Converted Organics, Inc.			(50,562,336	)			1,480,100				(49,082,236	)
Net loss per share, basic and diluted
Continuing operations			(3.40	)							(3.10	)
Discontinued operations			(7.40	)							(7.40	)
Net loss per share		$	(10.80	)						$	(10.50	)
As of December 31, 2010
Accounts receivable, net		$	579,946		$		(57,000	)		$	522,946
Intangible assets, net			11,629,265				250,000				11,879,265
Goodwill			1,667,957				691,421				2,359,378
Additional paid-in capital			85,555,990				(673,579	)			84,882,411
Accumulated deficit			(100,453,292	)			1,480,100				(98,973,192	)
Noncontrolling interests			576,178				77,900				654,078
Total stockholders equity			3,186,314				884,421				4,070,735

The Company also restated its financial statements for the three and six months ended June 30, 2011 to correct the Company’s accounting for the goodwill recorded in connection with the acquisition of TerraSphere in November, 2010. The Company restated those financial statements to record a charge of $2.1 million at June 30, 2011 reflecting the impairment of that goodwill. See Note 1.

The following sets forth the effect of the restatement on the affected financial statement line items as of and for the three and six months ended June 30, 2011:

CONVERTED ORGANICS INC.

		As previously				Restatement				As				As previously				Restatement				As
		reported				adjustment				restated				reported				adjustment				restated
		Three months ended June 30, 2011												Six months ended June 30, 2011
For the three and six months ended June 30, 2011
Impairment		$	—			$	2,135,021			$	2,135,021			$	—			$	2,135,021			$	2,135,021
Loss from continuing operations			(3,547,413	)			(2,135,021	)			(5,682,434	)			(5,867,016	)			(2,135,021	)			(8,002,037	)
Income (loss) from continuing operations before provision for income taxes			869,392				(2,135,021	)			(1,265,629	)			(930,581	)			(2,135,021	)			(3,065,602	)
Income (loss) from continuing operations			869,392				(2,135,021	)			(1,265,629	)			(930,581	)			(2,135,021	)			(3,065,602	)
Net income (loss)			1,016,362				(2,135,021	)			(1,118,659	)			(784,110	)			(2,135,021	)			(2,919,131	)
Net loss attributable to noncontrolling interest			(85,530	)			(106,751	)			(192,281	)			(146,525	)			(106,751	)			(253,276	)
Net income (loss) attributable to Converted Organics, Inc. before other comprehensive income			1,101,892				(2,028,270	)			(926,378	)			(637,585	)			(2,028,270	)			(2,665,855	)
Comprehensive income (loss)			1,098,084				(2,135,021	)			(1,036,937	)			(651,889	)			(2,135,021	)			(2,786,910	)
Comprehensive income (loss) attributable to
Converted Organics, Inc.			1,098,818				(2,028,270	)			(929,452	)			(649,135	)			(2,028,270	)			(2,677,405	)
Earnings (loss) per share, basic and diluted
Continuing operations		$	0.10							$	(0.10	)		$	(0.10	)						$	(0.30	)
Discontinued operations			—								—				—								—
		$	0.10							$	(0.10	)		$	(0.10	)						$	(0.30	)
As of June 30, 2011
Accounts receivable, net		$	1,075,509			$	(57,000	)		$	1,018,509
Goodwill			1,668,369				(1,193,600	)			474,769
Additional paid-in capital			99,470,282				(673,579	)			98,796,703
Accumulated deficit			(101,090,877	)			(548,170	)			(101,639,047	)
Noncontrolling interests			426,899				(28,851	)			398,048
Total stockholders equity			12,087,391				(1,143,849	)			10,943,542